Cancer Therapeutic Targets /
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2017.
|
| Edition: | 1st ed. 2017. |
| Subjects: |
Table of Contents:
- AKT
- Anti-4-1BB/4-1BBL
- Anti-B7-H4
- Anti-CD40/Anti CD40L
- Anti-Idiotype antibodies
- Anti-Programmed Death 1 (PD1)
- B7.1
- Bacterial Vaccines
- Brachyury
- CCL21
- CD4+ T Cells
- CD8 T Cells
- CEA
- CTLA-4
- Dendritic cells
- DNA Vaccines
- EGFR, Immunology
- Fc Gamma R
- Gangliosides
- Glucocorticoid-Induced TNF Receptor (GITR)
- GM-CSF and Whole Cells
- gp100
- HER2/neu
- indoleamine 2,3-dioxygenase
- Integrins, Immunology
- Interferon alpha
- Interleukin 2
- Interleukin 7
- Interleukin 12
- Interleukin 15
- Interleukin 21
- Lymphocyte Activation Gene 3 (LAG-3)
- MART-1
- MUC1
- NK Cells
- P53, Immunology
- PAP
- Peptide Vaccine: Overview
- Proteins (Mesothelin)
- PSA
- Survivin
- Telomerase-related proteins
- TGF Beta Receptors
- TLR7 and TLR8, Resiquimod, and 852A
- TLR9
- Transforming Growth Factor β
- Tregs
- Tyrosinase: Overview
- VEGF
- Viral-Like Proteins
- Whole-Cell Vaccines
- FGF-FGFR Signaling in Cancer
- MMPs
- PDGF
- TIE
- VEGF A
- VEGF Ligands
- AXL
- B-Raf
- CKIT
- DNA Repair, Overview
- EGFR, Growth factors
- HER3
- IGF 1 and IGF 2
- Jak2/Stat5a/b Pathway in Prostate Cancer
- JNK Signaling in Diseases
- K-Ras
- MET
- NEDD9
- N-Ras
- P38
- Rac 1
- Type I Insulin-Like Growth Factor Receptor
- Anti-apoptotic Bcl-2
- BH3-Only Mimetics
- Caspase
- DR4 and DR5
- FLIP
- MLH1
- NF-κB
- PARP
- ROS
- X-Linked IAP
- APC
- AR, Overview
- BRCA 1 and 2
- Cell Cycle Related Kinases
- ER
- Histone Deacetylases (HDAC)
- Methylation
- PR
- Retinoids
- Topoisomerase 1
- Topoisomerase 2
- VDR.